knowledge -WSS

knowledge

author：knowledge 2025-09-28 11:29:09 - browse：993

Stoke Therapeutics is still seeking an effective dose for an experimental drug to treat a severe form of childhood epilepsy, following the release of updated data Tuesday that showed disappointing reductions in convulsive seizure activity.

In the latest look at an ongoing mid-stage study, three monthly injections of the Stoke drug, called STK-001, given at a 45-mg dose, resulted in a median 18% reduction in convulsive seizure activity, compared to baseline.

The new analysis was conducted on 16 children diagnosed with a rare form of epilepsy called Dravet syndrome. Last November, in six patients, the drug showed a median 55% reduction in seizure activity.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Pancreatic cancer is often deadly, but new discoveries are raising hope

explore

WSS

Cholera vaccine supplies dangerously low, outbreaks surging

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Four alarming medical procedures we’re glad history forgot

Cholera vaccine supplies dangerously low, outbreaks surging

Multiple sclerosis has subtypes with different best treatments: study

Study: Black kids more likely to die after surgery than white kids

Wikipedia

knowledge

focus

23andMe had bad news about my health. I wish a person had delivered it

Medicare Advantage 2025 payments will dip, Biden administration says

Duchenne breakthrough therapy leaves behind pioneering families

Covid silver lining: Unprecedented look at human immune system

How one medical school became remarkably diverse

Oral obesity drug from Viking Therapeutics hits key early target

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Study: Black kids more likely to die after surgery than white kids

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Florida Supreme Court upholds state's abortion ban

focus

Elisabeth Bik tackles the widespread issue of research misconduct

NEJM study measures Covid brain fog, impact on IQ

Pfizer is about to make a big push in cancer. Will investors listen?

Study fuels hope CAR

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Scientific mystery highlights the blind spots in genomics databases

hotspot

explore

Wikipedia

focus